Charles River Laboratories International (CRL) Income from Continuing Operations (2009 - 2026)

Charles River Laboratories International's Income from Continuing Operations history runs 17 years deep, the most recent figure standing at 276290000.0 for Q4 2025.

• In Q4 2025, Income from Continuing Operations fell 29.26% year-over-year to 276290000.0; the TTM figure through Dec 2025 stood at 142163000.0 (down 662.11% YoY), while the FY2025 annual figure was 142163000.0, down 662.11% from the prior year.
• Income from Continuing Operations for Q4 2025 stood at 276290000.0, down from 55556000.0 in the prior quarter.
• The five-year high for Income from Continuing Operations was 189106000.0 in Q4 2022, with the low at 276290000.0 in Q4 2025.
• The 5-year median for Income from Continuing Operations is 92088500.0 (2021), against an average of 62747150.0.
• The sharpest annual moves came in 2022 and 2024: Income from Continuing Operations jumped 48.94% in 2022, then tumbled 213.12% in 2024.
• Charles River Laboratories International's Income from Continuing Operations stood at 139827000.0 in 2021, then jumped by 35.24% to 189106000.0 in 2022, then retreated by 0.08% to 188952000.0 in 2023, then sank by 213.12% to 213747000.0 in 2024, then retreated by 29.26% to 276290000.0 in 2025.
• Business Quant data shows CRL's Income from Continuing Operations at 276290000.0 in Q4 2025, 55556000.0 in Q3 2025, and 52693000.0 in Q2 2025.